During the past decade, Onkologische Schwerpunktpraxis Göttingen conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Onkologische Schwerpunktpraxis Göttingen" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Cancer Trials Ireland" with 1 trials as a collaborator, "Celerion" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "Israeli CLL Study Group" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Onkologische Schwerpunktpraxis Göttingen" are "Chronic Lymphocytic Leukemia" (1 trials), "Renal Cell Cancer, Recurrent" (1 trials) and "Renal Cell Carcinoma, Metastatic" (1 trials). Many other conditions were trialed in "Onkologische Schwerpunktpraxis Göttingen" in a lesser frequency.

Most popular intervention types in "Onkologische Schwerpunktpraxis Göttingen" are "Behavioral" (1 trials), "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bendamustine" (1 trials), "Concomitant coaching" (1 trials), "Cyclophosphamide" (1 trials), "Fludarabine" (1 trials) and "Ibrutinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Onkologische Schwerpunktpraxis Göttingen" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Onkologische Schwerpunktpraxis Göttingen". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Onkologische Schwerpunktpraxis Göttingen, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Onkologische Schwerpunktpraxis Göttingen, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".